A detailed history of Summit Financial Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Summit Financial Wealth Advisors, LLC holds 9,550 shares of NVO stock, worth $806,497. This represents 0.22% of its overall portfolio holdings.

Number of Shares
9,550
Previous 9,910 3.63%
Holding current value
$806,497
Previous $1.41 Million 19.59%
% of portfolio
0.22%
Previous 0.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $42,865 - $52,351
-360 Reduced 3.63%
9,550 $1.14 Million
Q1 2024

May 02, 2024

BUY
$102.11 - $135.92 $1.01 Million - $1.35 Million
9,910 New
9,910 $1.27 Million
Q4 2020

Jan 11, 2021

SELL
$63.89 - $73.8 $383,340 - $442,800
-6,000 Closed
0 $0
Q4 2018

Feb 01, 2019

SELL
$41.54 - $47.25 $16,782 - $19,089
-404 Reduced 6.31%
6,000 $276,000
Q3 2018

Oct 22, 2018

BUY
$46.76 - $51.24 $299,451 - $328,140
6,404 New
6,404 $270,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Summit Financial Wealth Advisors, LLC Portfolio

Follow Summit Financial Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Wealth Advisors, LLC with notifications on news.